• shareshare
  • link
  • cite
  • add
auto_awesome_motion View all 8 versions
Publication . Article . Other literature type . Review . 2020

Coronavirus Disease-19 : An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)

An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)
Bahaa Abu-Raya; Giovanni Battista Migliori; Miguel O'Ryan; Kathryn Edwards; Antoni Torres; Jan-Willem Alffenaar; Jan-Willem Alffenaar; +27 Authors
Open Access
Coronavirus disease 2019 (COVID-19) is a rapidly evolving, highly transmissible, and potentially lethal pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of June 11 2020, more than 7,000,000 COVID-19 cases have been reported worldwide, and more than 400,000 patients have died, affecting at least 188 countries. While literature on the disease is rapidly accumulating, an integrated, multinational perspective on clinical manifestations, immunological effects, diagnosis, prevention, and treatment of COVID-19 can be of global benefit. We aimed to synthesize the most relevant literature and experiences in different parts of the world through our global consortium of experts to provide a consensus-based document at this early stage of the pandemic. A-GM was funded by Marie Sklodowska-Curie Actions [Grant agreement no. 529 713660-PRONKJEWAIL-H2020-MSCA-COFUND-2015]. AT was supported by IDIBAPS, CIBERES, and ICREA. Esposito, S (corresponding author), Univ Parma, Pediat Clin, Dept Med & Surg, Pietro Barilla Childrens Hosp, Parma, Italy.
Subjects by Vocabulary

Library of Congress Subject Headings: lcsh:Medicine (General) lcsh:R5-920

Microsoft Academic Graph classification: Coronavirus disease 2019 (COVID-19) Intensive care medicine medicine.medical_specialty medicine Disease Transmission (medicine) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Pandemic Infection control Interim business.industry business Coronavirus medicine.disease_cause


COVID-19, coronavirus, intensive care management, prevention, workplace safety, infection control, SARS-CoV-2, physical distancing, RHEUMATOID-ARTHRITIS, CHLOROQUINE, BARICITINIB, EPIDEMIC, CHINA, WUHAN, TRANSMISSION, COMBINATION, WASHINGTON, Human medicine, General Medicine, Medicine, Review

Funded by
Protecting patients with enhanced susceptibility to infections
  • Funder: European Commission (EC)
  • Project Code: 713660
  • Funding stream: H2020 | MSCA-COFUND-DP
Validated by funder
Related to Research communities